Table 1.
N = 659 | |
---|---|
Participants | N (%) |
Country ofresidence | |
USA | 255 (38.7) |
Ghana | 318 (48.3) |
Italy | 86 (13.0) |
Age group(years) | N (%) |
Pediatric (< 18 years) | 240 (36.4) |
Mean age (range, sd) | 9.6 (1–17, 4.5) |
Adult (≥18 years old) | 419 (63.6) |
Mean age (range, sd) | 29.9 (18–73.9, 11.2) |
Gender | N (%) |
Male | 303 (46) |
Female | 356 (54) |
Sickle cell genotype | N (%) |
SS | 474 (75) |
SC | 168 (19.2) |
S Beta Thal + | 29 (3.3) |
S Beta Thal Zero | 22 (2.5) |
History of leg ulcer | N (%) |
Yes | 68 (10.3) |
No | 591 (89.7) |
Hydroxyurea use | N(%) |
Leg ulcer = yes | 3 (4.3) |
Leg ulcer = no | 65 (95.7) |